Picture of Sienna Biopharmaceuticals logo

SNNAQ — Sienna Biopharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Sienna Biopharmaceuticals Reports Q2 Loss Per Share Of $1.00

Aug 9 (Reuters) - Sienna Biopharmaceuticals Inc  SNNA.O :
    * SIENNA BIOPHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS
    * SIENNA BIOPHARMACEUTICALS INC QTRLY LOSS PER SHARE $1.00
    * SIENNA BIOPHARMACEUTICALS INC - CASH BURN DURING THREE
MONTHS
ENDED JUNE 30, 2018, WAS APPROXIMATELY $15.8 MILLION
    * SIENNA BIOPHARMACEUTICALS INC - SIENNA'S CASH AND CASH
EQUIVALENTS AS OF JUNE 30, 2018, TOTALED APPROXIMATELY $74.9
MILLION

Source text for Eikon:  ID:nGNX21kZ3D 
Further company coverage:  SNNA.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Sienna Biopharmaceuticals

See all news